Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339

Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signaling

Min Xiu, Juanjuan Xing, Shaoqing Yu et al. · Cellular Physiology and Biochemistry · 2017 · 5.8K citations · Full text

Life Sciences, Cell Biology, Immunology +17

An Organometallic Protein Kinase Inhibitor Pharmacologically Activates p53 and Induces Apoptosis in Human Melanoma Cells

Keiran S.M. Smalley, Rooha Contractor, Nikolas K. Haass et al. · Cancer Research · 2007 · 230 citations

Medicine, Oncology, Pharmacology +16

Redox behavior of tumor-inhibiting ruthenium(<scp>iii</scp>) complexes and effects of physiological reductants on their binding to GMP

Petra Schluga, Christian G. Hartinger, Alexander Egger et al. · Dalton Transactions · 2006 · 218 citations · Full text

Natural Sciences, Medicinal Chemistry, Pharmacology +16

A Ruthenium-Containing Organometallic Compound Reduces Tumor Growth through Induction of the Endoplasmic Reticulum Stress Gene <i>CHOP</i>

Xiangjun Meng, Mili L. Leyva, Marjorie Jenny et al. · Cancer Research · 2009 · 208 citations · Full text

Medicine, Oncology, Pharmacology +13

Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells

Susanne Kapitza, M. Pongratz, Michael A. Jakupec et al. · Journal of Cancer Research and Clinical Oncology · 2004 · 198 citations · Full text

Medicine, Cancer Biology, Oncology +11